Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AweMed Series is a Singapore-based skincare brand developed by Orendapharma in collaboration with local dermatologists and pediatricians. The company specializes in therapeutic solutions for sensitive and eczema-prone skin, focusing on restoring the skin barrier and providing rapid itch relief. Its core product portfolio includes the AweMed Spray for acute itch relief, the AweMed Repair+ Daily Moisturizer for skin integrity maintenance, and the AweMed Lipid+ Gentle Wash for non-stripping cleansing. The brand emphasizes clean formulations free from steroids, alcohol, parabens, and fragrances, making them suitable for all ages, including infants. AweMed Series actively engages with the eczema community in Singapore through educational initiatives and sponsorships of events like the annual Eczema Family Day.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AweMed Series.